Doctor profile · Federal record
Dr. Fernando Melaragno, DO
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Erie, PA
- NPI 1912161613
- Accepts Medicare
- 19 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5535 Peach St
Erie, PA 165092603
(814) 868-3488
fax (877) 857-2746 - Mailing address
-
1 Lecom Pl
Erie, PA 165052571
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- December 28, 2022
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #OS017221
- Medicaid
- PA #1029823750008
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1912161613. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
382
Distinct HCPCS
5
Medicare allowed
$27,395
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 205 | 103 | $93 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 69 | 69 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 50 | 21 | $33 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 39 | 39 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 19 | 19 | $63 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 76. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$2,885
Transactions
108
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 23 | $458.32 | |
| Lilly USA, LLC | 25 | $437.13 | |
| Madrigal Pharmaceuticals | 3 | $299.39 | |
| AstraZeneca Pharmaceuticals LP | 6 | $257.12 | |
| Amgen Inc. | 9 | $193.28 | |
| Abbott Laboratories | 3 | $170.53 | |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $142.88 | |
| Medtronic, Inc. | 2 | $124.44 | |
| Novartis Pharmaceuticals Corporation | 5 | $97.02 | |
| Xeris Pharmaceuticals, Inc. | 5 | $89.89 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85.02 | |
| Neurocrine Biosciences, Inc. | 3 | $79.52 | |
| CeQur Corporation | 1 | $61.89 | |
| Amneal Pharmaceuticals LLC | 2 | $53.02 | |
| Antares Pharma, Inc. | 3 | $52.76 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,197
Patients
511
Total drug cost
$1,835,130
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Jardiance (Empagliflozin) | Brand | 230 | 65 | $287,289 |
| Trulicity (Dulaglutide) | Brand | 218 | 46 | $328,089 |
| Levothyroxine Sodium | Generic | 209 | 50 | $3,312 |
| Mounjaro (Tirzepatide) | Brand | 196 | 30 | $241,858 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 186 | 54 | $4,541 |
| Metformin Hcl | Generic | 167 | 52 | $2,159 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 144 | 34 | $152,714 |
| Rybelsus (Semaglutide) | Brand | 135 | 35 | $175,810 |
| Ozempic (Semaglutide) | Brand | 128 | 30 | $198,782 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 125 | 33 | $70,933 |
Hospital affiliations
Frequently asked questions
What is Dr. Fernando Melaragno's medical specialty?
Dr. Fernando Melaragno practices Endocrinology, Diabetes & Metabolism Physician in Erie, PA.
Where does Dr. Fernando Melaragno practice?
Dr. Fernando Melaragno practices at 5535 Peach St, Erie, PA 165092603. Office phone: 8148683488.
What is Dr. Fernando Melaragno's NPI?
Dr. Fernando Melaragno's National Provider Identifier (NPI) is 1912161613, issued by NPPES.
Does Dr. Fernando Melaragno accept Medicare assignment?
Yes. Dr. Fernando Melaragno accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Fernando Melaragno commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Dxa bone density measurement of hip, pelvis, spine (HCPCS 77080); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.